Group B Streptococcus vaccine: financial analysis
This report describes the potential financial outcomes that can be expected from successful development of a GBS vaccine that can attain global registration. The report also assesses whether specific additional financing is required to support the clinical development activities. It builds on previous work that described potential scenarios of demand for a GBS vaccine.
